Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q2 2018 · 10-Q
Revenue$225.38M$225.38M+2.3% vs Q2 2017 Net Income$20.10M$20.10M+1.4% vs Q2 2017 EPS Diluted$0.38$0.38±0.0% vs Q2 2017 Gross Profit$104,562,000+0.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flowderived$58,903,000+50.0% Free Cash Flowderived$43,499,000+116.2% Margins · derivedGross margin46.4%−0.9 pt vs Q2 2017
Operating margin10.8%−0.5 pt vs Q2 2017
Net margin8.9%−0.1 pt vs Q2 2017
ended Sep 30, 2017 · filed Nov 7, 2017 · 38 d after period end